辛伐他汀-话题@MedSci

#辛伐他汀#

35篇内容 | 2295人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1368092, encodeId=b577136809251, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Lancet Neurol：辛伐他汀对进行性多发性硬化患者机体功能的改善, objectType=article, longId=100971, objectId=05921009e1d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05921009e1d6, replyNumber=0, likeNumber=90, createdTime=2017-06-09, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05921009e1d6, moduleTitle=Lancet Neurol：辛伐他汀对进行性多发性硬化患者机体功能的改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05921009e1d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368091, encodeId=acbd1368091a4, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用, objectType=article, longId=100591, objectId=6072100591b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6072100591b0, replyNumber=0, likeNumber=69, createdTime=2017-06-04, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6072100591b0, moduleTitle=CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6072100591b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368090, encodeId=b939136809024, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Crit Care：辛伐他汀治疗ARDS具有较好的成本效益, objectType=article, longId=100175, objectId=82ff1001e563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82ff1001e563, replyNumber=0, likeNumber=69, createdTime=2017-06-01, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82ff1001e563, moduleTitle=Crit Care：辛伐他汀治疗ARDS具有较好的成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82ff1001e563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368089, encodeId=f41213680891f, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=JASN：肾功能降低患者依折麦布加入辛伐他汀治疗的临床效益！, objectType=article, longId=99102, objectId=44359910210, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44359910210, replyNumber=0, likeNumber=78, createdTime=2017-05-20, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44359910210, moduleTitle=JASN：肾功能降低患者依折麦布加入辛伐他汀治疗的临床效益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44359910210)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368088, encodeId=16d813680889b, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？, objectType=article, longId=99007, objectId=f9689900e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9689900e21, replyNumber=0, likeNumber=67, createdTime=2017-05-19, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9689900e21, moduleTitle=Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9689900e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368087, encodeId=4f2a136808e0e, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=关注：辛伐他汀用药警示, objectType=article, longId=72044, objectId=5369e204483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5369e204483, replyNumber=0, likeNumber=65, createdTime=2016-07-06, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5369e204483, moduleTitle=关注：辛伐他汀用药警示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5369e204483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368086, encodeId=c51d136808697, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读), objectType=article, longId=69923, objectId=3f0f6992392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0f6992392, replyNumber=0, likeNumber=74, createdTime=2016-06-06, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0f6992392, moduleTitle=Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f0f6992392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368085, encodeId=94df136808514, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=JACC：依折麦布/辛伐他汀联合降脂治疗可提高ACS患者的临床疗效, objectType=article, longId=62636, objectId=61b562636da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61b562636da, replyNumber=0, likeNumber=71, createdTime=2016-01-28, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61b562636da, moduleTitle=JACC：依折麦布/辛伐他汀联合降脂治疗可提高ACS患者的临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61b562636da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368084, encodeId=52c01368084b4, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Gastroenterology：辛伐他汀在降低肝硬化食管静脉曲张破裂出血患者中的作用, objectType=article, longId=62581, objectId=1bbf62581c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bbf62581c0, replyNumber=0, likeNumber=67, createdTime=2016-01-27, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bbf62581c0, moduleTitle=Gastroenterology：辛伐他汀在降低肝硬化食管静脉曲张破裂出血患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bbf62581c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368083, encodeId=82bc13680837f, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Circulation：依折麦布/辛伐他汀可以更好地降低LDL-C和hs-CRP（IMPROVE-IT试验）, objectType=article, longId=55704, objectId=022755e040e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022755e040e, replyNumber=0, likeNumber=69, createdTime=2015-09-04, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022755e040e, moduleTitle=Circulation：依折麦布/辛伐他汀可以更好地降低LDL-C和hs-CRP（IMPROVE-IT试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022755e040e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368082, encodeId=f51f136808235, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Heart：预防外周动脉疾病选阿托伐他汀还是辛伐他汀？, objectType=article, longId=45766, objectId=f90645e66a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90645e66a8, replyNumber=0, likeNumber=101, createdTime=2015-01-22, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90645e66a8, moduleTitle=Heart：预防外周动脉疾病选阿托伐他汀还是辛伐他汀？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f90645e66a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368081, encodeId=abda13680819a, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=NEJM：辛伐他汀并不能改变COPD急性发作, objectType=article, longId=36235, objectId=d98236235e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98236235e3, replyNumber=0, likeNumber=101, createdTime=2014-06-12, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98236235e3, moduleTitle=NEJM：辛伐他汀并不能改变COPD急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98236235e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368080, encodeId=ea481368080a9, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=CCP：辛伐他汀可增强化疗抑制细胞生长的效果, objectType=article, longId=34279, objectId=6b91342e9ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b91342e9ec, replyNumber=0, likeNumber=110, createdTime=2014-05-07, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b91342e9ec, moduleTitle=CCP：辛伐他汀可增强化疗抑制细胞生长的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b91342e9ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368079, encodeId=733013680e9b2, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=JAMA：辛伐他汀不能改善呼吸机相关性肺炎患者第28天时的生存率, objectType=article, longId=25674, objectId=fd07256e4a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd07256e4a3, replyNumber=0, likeNumber=74, createdTime=2013-10-24, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd07256e4a3, moduleTitle=JAMA：辛伐他汀不能改善呼吸机相关性肺炎患者第28天时的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd07256e4a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368078, encodeId=451313680e8e5, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效, objectType=article, longId=25615, objectId=f3ee2561559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ee2561559, replyNumber=0, likeNumber=74, createdTime=2013-10-23, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ee2561559, moduleTitle=Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ee2561559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368077, encodeId=6c7d13680e76c, content=<a href='/topic/show?id=f2fd938442c' target=_blank style='color:#2F92EE;'>#辛伐他汀#</a>, objectTitle=FDA准降糖降脂(西格列汀和辛伐他汀)复方制剂上市, objectType=article, longId=3242, objectId=226c3242f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=226c3242f8, replyNumber=0, likeNumber=88, createdTime=2011-11-02, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=226c3242f8, moduleTitle=FDA准降糖降脂(西格列汀和辛伐他汀)复方制剂上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=226c3242f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

辛伐他汀

2020-05-29

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Lancet Neurol：辛伐他汀对进行性多发性硬化患者机体功能的改善

2017-06-09

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用

2017-06-04

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Crit Care：辛伐他汀治疗ARDS具有较好的成本效益

2017-06-01

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

JASN：肾功能降低患者依折麦布加入辛伐他汀治疗的临床效益！

2017-05-20

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？

2017-05-19

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

关注：辛伐他汀用药警示

2016-07-06

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读)

2016-06-06

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

JACC：依折麦布/辛伐他汀联合降脂治疗可提高ACS患者的临床疗效

2016-01-28

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Gastroenterology：辛伐他汀在降低肝硬化食管静脉曲张破裂出血患者中的作用

2016-01-27

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Circulation：依折麦布/辛伐他汀可以更好地降低LDL-C和hs-CRP（IMPROVE-IT试验）

2015-09-04

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Heart：预防外周动脉疾病选阿托伐他汀还是辛伐他汀？

2015-01-22

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

NEJM：辛伐他汀并不能改变COPD急性发作

2014-06-12

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

CCP：辛伐他汀可增强化疗抑制细胞生长的效果

2014-05-07

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

JAMA：辛伐他汀不能改善呼吸机相关性肺炎患者第28天时的生存率

2013-10-24

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效

2013-10-23

zhangmingxiang (审核中...)

前往app查看评论内容

#辛伐他汀#

FDA准降糖降脂(西格列汀和辛伐他汀)复方制剂上市

2011-11-02

科室
- - 订阅+
  - 更多科室
工具
服务